Treatment of acute ST elevation myocardial infarction in a regional network ("Drip&Ship network Rostock");Behandlung des akuten ST-hebungsinfarkts in netzwerkstrukturen: "Drip&Ship - Das Rostocker infarktmodell"

Herz

Volumn 32, Issue 8, 2007, Pages 635-640

  Schneider, Henrik ^b   Ince, Hüseyin ^b   Rehders, Tim ^b   Körber, Thomas ^b   Weber, Frank ^b   Kische, Stephan ^b   Chatterjee, Tuchaar ^b   Nienaber, Christoph A ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b NONE

Author keywords

Acute myocardial infarction; Network logistics; Primary PCI

Indexed keywords

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; CARDIOLOGIST; EMERGENCY PHYSICIAN; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HOSPITAL; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REVIEW; RURAL AREA; ST SEGMENT ELEVATION;

ATHERECTOMY; CARDIOLOGY; COMMUNITY NETWORKS; CRITICAL PATHWAYS; DECISION SUPPORT SYSTEMS, CLINICAL; DELIVERY OF HEALTH CARE; DELIVERY OF HEALTH CARE, INTEGRATED; GERMANY; HUMANS; MODELS, ORGANIZATIONAL; MYOCARDIAL INFARCTION; REGIONAL HEALTH PLANNING; THROMBOLYTIC THERAPY;

EID: 36949016383     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-007-3061-5     Document Type: Review

References (19)

1. Andersen HR, Nielsen TT, Rasmussen K, et al. for the DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42.
2. Antoniucci D, Migliorini A, Parodi G, et al. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicentre, randomized trial comparing infarct artery stenting plus abciximab with stenting alone. Circulation 2004;109:1704-6.
3. ASSENT-4 PCI Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006;367:569-78.
4. Boersma E, and the Primary Coronary Angioplasty vs. Thrombolysis (PCAT)-2 Trialists' Collaborative Group. Does time matter? A pooled analysis of randomised clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006;27:779-88.
5. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) Study Group. Lancet 2002;360:825-9.
6. Bonnefoy E, Steg PG, Cabaud S, et al. Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomised clinical trial. Eur Heart J 2005;26:1712-8.
7. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7.
8. Hamm CW, Arntz HR, Bode C, et al. Leitlinien Akutes Koronarsyndrom, Teil 2: Akutes Koronarsyndrom mit ST-Hebung. Z Kardiol 2004;93:324-41.
9. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003;361:13-20.
10. Montalescot G, Barragan P, Wittenberg O, et al., for the ADMIRAL Investigators. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2002;344:1895-903.
11. Nallamothu, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 2003;92:824-6.
12. Ross AM, Coyne KS, Reiner JS, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT Investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol 1999;34:1954-62.
13. Schömig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 2000;343:385-91.
14. Steg PG, Bonnefoy E, Chaubaud S, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Circulation 2003;108:2851-6.
15. Stenestrand U, Lindbäck J, Wallentin L. Long term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296:1749-56.
16. Verheugt FW. GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction [Review]. Thromb Res 2001;103:Suppl 1:113-6.
17. Vermeer F, Ophuis AJ, Berg EJ, et al. Prospective randomised comparison between thrombolysis, rescue PCI, and primary PCI in patients with extensive myocardial infarction admitted to a hospital without PCI facilities: a safety and feasibility study. Heart 1999;82:426-31.
18. Widimsky P, Budesinsky T, Vorac D, et al., "PRAGUE" Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial PRAGUE-2. Eur Heart J 2003;24:94-104.
19. Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000;21:823-31.